The cost-effectiveness of returning incidental findings from next-generation genomic sequencing

Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia

(2014) Zanfina Ademi et al.   Journal of Clinical Lipidology

Actionable, Pathogenic Incidental Findings in 1,000 Participants’ Exomes

(2013) Michael O. Dorschner et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer

(2013) Uri Ladabaum et al.   ANNALS OF INTERNAL MEDICINE

Recommendations for returning genomic incidental findings? We need to talk!

(2013) Wylie Burke et al.   GENETICS IN MEDICINE

Genetic incidental findings: autonomy regained?

(2013) Effy Vayena et al.   GENETICS IN MEDICINE

Return of incidental findings in genomic medicine: measuring what patients value—development of an instrument to measure preferences for information from next-generation testing (IMPRINT)

(2013) Caroline Savage Bennette et al.   GENETICS IN MEDICINE

Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing

(2013) Barbara J. Evans   GENETICS IN MEDICINE

Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium

(2013) Jonathan S. Berg et al.   GENETICS IN MEDICINE

Paternalism and the ACMG recommendations on genomic incidental findings: patients seen but not heard

(2013) Anne Townsend et al.   GENETICS IN MEDICINE

ACMG recommendations on incidental findings are flawed scientifically and ethically

(2013) Neil A. Holtzman   GENETICS IN MEDICINE

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

(2013) Robert C. Green et al.   GENETICS IN MEDICINE

Who's on first in exome and whole genome sequencing? Is it the patient or the incidental findings?

(2013) David S. Rosenblatt   MOLECULAR GENETICS AND METABOLISM

Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing

(2013) Megan Allyse et al.   TRENDS IN BIOTECHNOLOGY

Policy challenges of clinical genome sequencing

(2013) C. F. Wright et al.   BMJ-British Medical Journal

Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome

(2012) Miriam Kuppermann et al.   CANCER

Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer

(2012) Shelby D. Reed et al.   GENETICS IN MEDICINE

The Cost-Effectiveness of Primary Stroke Centers for Acute Stroke Care

(2012) Gregory F. Guzauskas et al.   STROKE

Influence of Patient Preferences on the Cost-Effectiveness of Screening for Lynch Syndrome

(2012) Grace Wang et al.   Journal of Oncology Practice

Future Directions in Malignant Hyperthermia Research and Patient Care

(2011) Sharon J. Hirshey Dirksen et al.   ANESTHESIA AND ANALGESIA

Economic evaluation of targeted cancer interventions: Critical review and recommendations

(2011) Elena B. Elkin et al.   GENETICS IN MEDICINE

A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy

(2011) Jodie Ingles et al.   HEART

Resource Use in the Last 6 Months of Life Among Medicare Beneficiaries With Heart Failure, 2000-2007

(2010) Kathleen T. Unroe et al.   ARCHIVES OF INTERNAL MEDICINE

Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population

(2010) T. A. Dinh et al.   Cancer Prevention Research

Cost-Effectiveness of Genetic Testing in Family Members of Patients With Long-QT Syndrome

(2010) Marco V. Perez et al.  

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model

(2010) S. Wordsworth et al.   EUROPEAN HEART JOURNAL

The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer

(2010) Mercy Mvundura et al.   GENETICS IN MEDICINE

Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia

(2009) L. Nherera et al.   CURRENT MEDICAL RESEARCH AND OPINION

Evaluating the utility of personal genomic information

(2009) Morris W Foster et al.   GENETICS IN MEDICINE

Efficacy of Antiarrhythmic Drugs in Arrhythmogenic Right Ventricular Cardiomyopathy

(2009) Gregory M. Marcus et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II

(2009) Louis P. Garrison et al.   VALUE IN HEALTH

Variation of Breast Cancer Risk Among BRCA1/2 Carriers

(2008) Colin B. Begg et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations

(2008) Susan M. Wolf et al.   JOURNAL OF LAW MEDICINE & ETHICS

Cost-Effectiveness of Testing for Breast Cancer Susceptibility Genes

(2008) Margaret L. Holland et al.   VALUE IN HEALTH